BDRX
Price
$6.51
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
UBX
Price
$1.40
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
Ad is loading...

BDRX vs UBX

Header iconBDRX vs UBX Comparison
Open Charts BDRX vs UBXBanner chart's image
Biodexa Pharmaceuticals
Price$6.51
Change-$0.00 (-0.00%)
Volume$51.99K
CapitalizationN/A
Unity Biotechnology
Price$1.40
Change-$0.00 (-0.00%)
Volume$31.38K
CapitalizationN/A
View a ticker or compare two or three
BDRX vs UBX Comparison Chart
Loading...
BDRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BDRX vs. UBX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Buy and UBX is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (BDRX: $6.51 vs. UBX: $1.40)
Brand notoriety: BDRX and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 24% vs. UBX: 78%
Market capitalization -- BDRX: $4.18M vs. UBX: $24.43M
BDRX [@Biotechnology] is valued at $4.18M. UBX’s [@Biotechnology] market capitalization is $24.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDRX and UBX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 5 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • BDRX’s TA Score: 5 bullish, 3 bearish.
  • UBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BDRX is a better buy in the short-term than UBX.

Price Growth

BDRX (@Biotechnology) experienced а +8.86% price change this week, while UBX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BDRX is expected to report earnings on Nov 30, 2022.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UBX($24.4M) has a higher market cap than BDRX($4.18M). UBX YTD gains are higher at: -27.461 vs. BDRX (-90.284).
BDRXUBXBDRX / UBX
Capitalization4.18M24.4M17%
EBITDAN/A-28.64M-
Gain YTD-90.284-27.461329%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A34M-
Total DebtN/A21.7M-
FUNDAMENTALS RATINGS
BDRX vs UBX: Fundamental Ratings
BDRX
UBX
OUTLOOK RATING
1..100
275
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
48
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9678
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDRX's Valuation (24) in the Biotechnology industry is in the same range as UBX (48). This means that BDRX’s stock grew similarly to UBX’s over the last 12 months.

BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as UBX (100). This means that BDRX’s stock grew similarly to UBX’s over the last 12 months.

UBX's SMR Rating (98) in the Biotechnology industry is in the same range as BDRX (99). This means that UBX’s stock grew similarly to BDRX’s over the last 12 months.

UBX's Price Growth Rating (78) in the Biotechnology industry is in the same range as BDRX (96). This means that UBX’s stock grew similarly to BDRX’s over the last 12 months.

BDRX's P/E Growth Rating (94) in the Biotechnology industry is in the same range as UBX (100). This means that BDRX’s stock grew similarly to UBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDRXUBX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
BDRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
+3.17%
LVTX - BDRX
41%
Loosely correlated
+2.00%
SCNI - BDRX
32%
Poorly correlated
+0.58%
ATNF - BDRX
32%
Poorly correlated
-0.70%
ATXI - BDRX
31%
Poorly correlated
+14.55%
AVTX - BDRX
31%
Poorly correlated
-2.35%
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with NCNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
+4.48%
NCNA - UBX
42%
Loosely correlated
-1.68%
KOD - UBX
40%
Loosely correlated
-0.27%
CHRS - UBX
37%
Loosely correlated
-7.97%
COGT - UBX
36%
Loosely correlated
-0.67%
XFOR - UBX
35%
Loosely correlated
+2.88%
More